Concepedia

Joël Robichaud

JR

26

Publications

2K

Citations

23

H-Index

1998

Active since

Affiliations

Merck Canada Inc. (Canada)(Current)

TransCanada (Canada)

Université de Moncton

United States Military Academy

Merck & Co., Inc., Rahway, NJ, USA (United States)

Joël Robichaud is an author at Merck Canada Inc. (Canada) specializing in natural sciences, biochemistry, and drug discovery.

Top concepts

BiochemistryNatural SciencesPharmacologyDrug DiscoveryMedicineMedicinal ChemistryEngineeringDrug DevelopmentChemistryOrganic Chemistry

Publications per year

1998–2014

26

Publications

26

The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K

Jacques Yves Gauthier, Nathalie Chauret, Wanda Cromlish et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 467 citations · Full text

Molecular Pharmacology, Pharmaceutical Chemistry, Biochemistry +11

Phonon confinement studies in nanocrystalline anatase‐TiO<sub>2</sub> thin films by micro Raman spectroscopy

S. Balaji, Yahia Djaoued, Joël Robichaud · Journal of Raman Spectroscopy · 2006 · 210 citations

Materials Science, Micro Raman Spectroscopy, Anatase Phase +15

Hydrothermal synthesis and electronic properties of FeWO4 and CoWO4 nanostructures

S. Rajagopal, D. Nataraj, O.Yu. Khyzhun et al. · Journal of Alloys and Compounds · 2009 · 169 citations

Materials Science, Functional Nanomaterials, Engineering +8

Trifluoroethylamines as amide isosteres in inhibitors of cathepsin K

W. Cameron Black, Christopher I. Bayly, Dana Davis et al. · Bioorganic & Medicinal Chemistry Letters · 2005 · 137 citations

Medicinal Chemistry, Derivative (Chemistry), Biochemistry +8

Study of Anatase to Rutile Phase Transition in Nanocrystalline Titania Films

Yahia Djaoued, Simona Bǎdilescu, P. V. Ashrit et al. · Journal of Sol-Gel Science and Technology · 2002 · 134 citations

Rows per page

1–5 of 26